205 related articles for article (PubMed ID: 28807916)
1. Inhibition of Calcineurin or IMP Dehydrogenase Exerts Moderate to Potent Antiviral Activity against Norovirus Replication.
Dang W; Yin Y; Wang Y; Wang W; Su J; Sprengers D; van der Laan LJW; Felczak K; Pankiewicz KW; Chang KO; Koopmans MPG; Metselaar HJ; Peppelenbosch MP; Pan Q
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807916
[TBL] [Abstract][Full Text] [Related]
2. Nitazoxanide Inhibits Human Norovirus Replication and Synergizes with Ribavirin by Activation of Cellular Antiviral Response.
Dang W; Xu L; Ma B; Chen S; Yin Y; Chang KO; Peppelenbosch MP; Pan Q
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30104275
[TBL] [Abstract][Full Text] [Related]
3. Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus.
Wang Y; Zhou X; Debing Y; Chen K; Van Der Laan LJ; Neyts J; Janssen HL; Metselaar HJ; Peppelenbosch MP; Pan Q
Gastroenterology; 2014 Jun; 146(7):1775-83. PubMed ID: 24582714
[TBL] [Abstract][Full Text] [Related]
4. 2'-Fluoro-2'-deoxycytidine inhibits murine norovirus replication and synergizes MPA, ribavirin and T705.
Yu P; Wang Y; Li Y; Li Y; Miao Z; Peppelenbosch MP; Pan Q
Arch Virol; 2020 Nov; 165(11):2605-2613. PubMed ID: 32770483
[TBL] [Abstract][Full Text] [Related]
5. Cross Talk between Nucleotide Synthesis Pathways with Cellular Immunity in Constraining Hepatitis E Virus Replication.
Wang Y; Wang W; Xu L; Zhou X; Shokrollahi E; Felczak K; van der Laan LJ; Pankiewicz KW; Sprengers D; Raat NJ; Metselaar HJ; Peppelenbosch MP; Pan Q
Antimicrob Agents Chemother; 2016 May; 60(5):2834-48. PubMed ID: 26926637
[TBL] [Abstract][Full Text] [Related]
6. Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon.
Markland W; McQuaid TJ; Jain J; Kwong AD
Antimicrob Agents Chemother; 2000 Apr; 44(4):859-66. PubMed ID: 10722482
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis C Virus infection in vitro and in vivo.
Pan Q; de Ruiter PE; Metselaar HJ; Kwekkeboom J; de Jonge J; Tilanus HW; Janssen HL; van der Laan LJ
Hepatology; 2012 Jun; 55(6):1673-83. PubMed ID: 22213147
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of new immunosuppressants.
Halloran PF
Clin Transplant; 1996 Feb; 10(1 Pt 2):118-23. PubMed ID: 8680047
[TBL] [Abstract][Full Text] [Related]
9. The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA.
Zhou S; Liu R; Baroudy BM; Malcolm BA; Reyes GR
Virology; 2003 Jun; 310(2):333-42. PubMed ID: 12781720
[TBL] [Abstract][Full Text] [Related]
10. In vitro combination of amdoxovir and the inosine monophosphate dehydrogenase inhibitors mycophenolic acid and ribavirin demonstrates potent activity against wild-type and drug-resistant variants of human immunodeficiency virus type 1.
Borroto-Esoda K; Myrick F; Feng J; Jeffrey J; Furman P
Antimicrob Agents Chemother; 2004 Nov; 48(11):4387-94. PubMed ID: 15504868
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolic acid inhibits hepatitis C virus replication and acts in synergy with cyclosporin A and interferon-alpha.
Henry SD; Metselaar HJ; Lonsdale RC; Kok A; Haagmans BL; Tilanus HW; van der Laan LJ
Gastroenterology; 2006 Nov; 131(5):1452-62. PubMed ID: 17101321
[TBL] [Abstract][Full Text] [Related]
12. Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus.
Ölschläger S; Neyts J; Günther S
Antiviral Res; 2011 Aug; 91(2):89-93. PubMed ID: 21616094
[TBL] [Abstract][Full Text] [Related]
13. Post-exposure antiviral treatment of norovirus infections effectively protects against diarrhea and reduces virus shedding in the stool in a mortality mouse model.
Rocha-Pereira J; Kolawole AO; Verbeken E; Wobus CE; Neyts J
Antiviral Res; 2016 Aug; 132():76-84. PubMed ID: 27252124
[TBL] [Abstract][Full Text] [Related]
14. Activity of ribavirin against Hantaan virus correlates with production of ribavirin-5'-triphosphate, not with inhibition of IMP dehydrogenase.
Sun Y; Chung DH; Chu YK; Jonsson CB; Parker WB
Antimicrob Agents Chemother; 2007 Jan; 51(1):84-8. PubMed ID: 17060520
[TBL] [Abstract][Full Text] [Related]
15. Norovirus: targets and tools in antiviral drug discovery.
Rocha-Pereira J; Neyts J; Jochmans D
Biochem Pharmacol; 2014 Sep; 91(1):1-11. PubMed ID: 24893351
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of the IMPDH enzyme as potential anti-bovine viral diarrhoea virus agents.
Stuyver LJ; Lostia S; Patterson SE; Clark JL; Watanabe KA; Otto MJ; Pankiewicz KW
Antivir Chem Chemother; 2002 Nov; 13(6):345-52. PubMed ID: 12718406
[TBL] [Abstract][Full Text] [Related]
17. The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase.
Leyssen P; Balzarini J; De Clercq E; Neyts J
J Virol; 2005 Feb; 79(3):1943-7. PubMed ID: 15650220
[TBL] [Abstract][Full Text] [Related]
18. Cellular IMPDH enzyme activity is a potential target for the inhibition of Chikungunya virus replication and virus induced apoptosis in cultured mammalian cells.
Khan M; Dhanwani R; Patro IK; Rao PV; Parida MM
Antiviral Res; 2011 Jan; 89(1):1-8. PubMed ID: 21070810
[TBL] [Abstract][Full Text] [Related]
19. The IMPDH inhibitors, ribavirin and mycophenolic acid, inhibit peste des petits ruminants virus infection.
Chang QY; Guo FC; Li XR; Zhou JH; Cai X; Pan Q; Ma XX
Vet Res Commun; 2018 Dec; 42(4):309-313. PubMed ID: 30094586
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin.
Barnard DL; Day CW; Bailey K; Heiner M; Montgomery R; Lauridsen L; Winslow S; Hoopes J; Li JK; Lee J; Carson DA; Cottam HB; Sidwell RW
Antiviral Res; 2006 Aug; 71(1):53-63. PubMed ID: 16621037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
